Compare AVXL & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | LQDT |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.6M | 859.6M |
| IPO Year | N/A | 2006 |
| Metric | AVXL | LQDT |
|---|---|---|
| Price | $4.01 | $31.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $22.00 | ★ $38.50 |
| AVG Volume (30 Days) | ★ 4.1M | 224.8K |
| Earning Date | 11-25-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.09 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $476,669,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.57 |
| Revenue Growth | N/A | ★ 31.20 |
| 52 Week Low | $2.86 | $21.67 |
| 52 Week High | $14.44 | $39.72 |
| Indicator | AVXL | LQDT |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 76.10 |
| Support Level | $3.96 | $29.72 |
| Resistance Level | $4.88 | $31.96 |
| Average True Range (ATR) | 0.41 | 0.78 |
| MACD | 0.20 | 0.24 |
| Stochastic Oscillator | 55.44 | 97.71 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.